Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Tilray, Inc.    TLRY

TILRAY, INC.

(TLRY)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/22/2020 09/23/2020 09/24/2020 09/25/2020 09/28/2020 Date
5.365(c) 4.7(c) 4.75(c) 4.79(c) 4.82(c) Last
11 386 804 10 972 026 5 476 370 4 146 554 5 201 830 Volume
+7.30% -12.40% +1.06% +0.84% +0.63% Change
More quotes
Financials (USD)
Sales 2020 227 M - -
Net income 2020 -307 M - -
Net cash position 2020 356 M - -
P/E ratio 2020 -1,83x
Yield 2020 -
Sales 2021 345 M - -
Net income 2021 -71,2 M - -
Net cash position 2021 475 M - -
P/E ratio 2021 -7,98x
Yield 2021 -
Capitalization 609 M 609 M -
EV / Sales 2020 1,11x
EV / Sales 2021 0,39x
Nbr of Employees 1 646
Free-Float 34,8%
More Financials
Company
Tilray Inc is engaged in pharmaceutical sector. The Company is a supplier of cannabis products to pharmaceutical distributors. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Through its subsidiary, FHF Holdings Ltd (Manitoba Harvest) manufactures, markets and distributes hemp-based consumer products. The portfolio of Manitoba Harvest... 
Sector
Pharmaceuticals
Calendar
11/17Earnings Release
More about the company
Notations Surperformance© of Tilray, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about TILRAY, INC.
11:26aNELSON PELTZ : Billionaire investor Peltz steps down as adviser at pot producer ..
RE
05:01aTILRAY : Medical Cannabis Product Shows Promise Reducing Nausea and Vomiting Cau..
BU
09/24TSX drops as pandemic aid fails to offset virus worries
RE
09/23TSX falls 2.02% to 15,817.11
RE
09/22Aurora Cannabis sees first-quarter revenue below estimates, shares fall
RE
09/22Aurora Cannabis sees Q1 revenue below estimates, shares fall
RE
09/22TSX rises 1.01% to 16,142.89
RE
09/11TSX rises as U.S. tech stock rout cools
RE
09/10Canada police bust weed trade using low-flying helicopter across U.S. border
RE
09/04TSX falls 1.4% to 16,218.01
RE
09/02TSX rises 0.79% to 16,644.99
RE
08/31Yelp joins 15 Percent Pledge to increase representation of Black-owned busine..
RE
08/31Yelp joins 15 Percent Pledge to increase representation of Black-owned busine..
RE
08/25Inner Spirit Holdings Announces Second Quarter 2020 Financial Results with Ov..
AQ
08/24TSX rises on gains in energy firms, COVID-19 treatment hopes
RE
More news
News in other languages on TILRAY, INC.
09/03Israël-Un drone largue du cannabis au dessus de Tel Aviv
08/21Dermapharm enttäuscht trotz höherer Prognose - Aktie verliert
08/18BERICHT : Drogenhändler nutzen Instagram als Umschlagplatz
08/11WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
08/11WALL STREET STOCK EXCHANGE : USA-Les valeurs à suivre à Wall Street (actualisé)
More news
Chart TILRAY, INC.
Duration : Period :
Tilray, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TILRAY, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Average target price 9,15 $
Last Close Price 4,79 $
Spread / Highest target 213%
Spread / Average Target 91,1%
Spread / Lowest Target 16,9%
EPS Revisions
Managers
NameTitle
Brendan Kennedy President, Chief Executive Officer & Director
Jon Levin Chief Operating Officer
Michael Kruteck Chief Financial Officer
Joshua Eades Chief Science Officer & Vice President
Christine Thompson St. Clare Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TILRAY, INC.-72.04%609
JOHNSON & JOHNSON-0.14%383 497
ROCHE HOLDING AG5.40%304 339
MERCK & CO., INC.-8.82%209 750
PFIZER, INC.-7.99%200 326
NOVARTIS AG-12.61%190 402